The forum provides a unique platform for Australian and Chinese life science researchers from industry and academia to showcase and commercialise cutting-edge biomedical discoveries in treating infections, cancer, neurological disorders, cardiovascular and metabolic diseases and regenerative medicine.

Session Topics (*subject to change) will focus on Intellectual Property issues and determining commercial viability, investor management and supply chain considerations (Day 1 – Monday 26th June) and immuno-oncology, gene therapy, and computational biology (Day 2 – Tuesday 27th June).

The forum will also provide opportunities to network and foster commercial collaboration.

Target Audience

2023 Australia – China Science and Innovation Forum invites participants from academia, industry including small and large biotechnology companies and pharmaceuticals, bio entrepreneurs and investors, and service providers to engage with leading-edge researchers from Australia and China to advance the translation and commercialisation of tomorrow’s therapies.

Marketing and promotion

Marketing and promotion for the 2023 Australia – China Science and Innovation Forum will be through appropriate forms of digital marketing, including email, e-brochures and social media. A targeted communications and promotion strategy will be developed, leveraging the communications channels available through other CCRM Hubs and existing contacts and partners.

Sponsorship form can be found via this link.

Direct enquiries by email to Dr Chih Wei Teng at chihwei.teng@ccrmaustralia.com.au or Dr Shi Qiu at lavine.qiu@monash.edu